SEC Form 4 · accession 0001181431-15-005467

Intra-Cellular Therapies, Inc. · ITCI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Mar 31, 2015

Accepted (ET)

Apr 2, 2015 · 4:58 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001567514

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Mar 31, 2015	A	450	$0.00	A	3,118	D
Common Stock	Mar 31, 2015	M	5,000	$0.96	A	8,118	D
Common Stock	Mar 31, 2015	M	10,000	$1.36	A	18,118	D
Common Stock	holding	—	—		—	15,742	I	Held by the Joel S. Marcus and Barbara A. Marcus Family Trust
Common Stock^F1	holding	—	—		—	1,283,856	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F2	$0.96	Mar 31, 2015	M	5,000	D	—	Apr 24, 2016	Common Stock	5,000	0	D
Stock Option (right to buy)^F2	$1.36	Mar 31, 2015	M	10,000	D	—	Dec 5, 2016	Common Stock	10,000	0	D

F1Consists of shares of common stock held by Alexandria Equities, LLC. Mr. Marcus is the Chairman, CEO and Founder of Alexandria Real Estate Equities, Inc., which is the managing member of Alexandria Equities, LLC, which has full voting and investment power with respect to the shares owned by Alexandria Equities, LLC. As an officer of Alexandria Real Estate Equities, Inc., Mr. Marcus may be deemed to have voting and investment power with respect to the shares owned by Alexandria Equities, LLC. Mr. Marcus disclaims beneficial ownership of the shares held by Alexandria Equities, LLC, except to the extent of his underlying pecuniary interest therein.
F2All shares underlying this option have vested.